This is a single-center, double-blind, placebo-controlled, randomized, single dose, fixed order, dose escalating inpatient design that will study oral NS2359 in cocaine experienced volunteers.
The purpose of this study is to conduct a drug interaction study with NS2359 and cocaine in cocaine experienced volunteers.